JEFFREY W WILLIAMS, O.D.
Optometry at Bunker Lake Blvd, Anoka, MN

License number
Minnesota 2506
Category
Optometry
Type
Optometrist
Address
Address
3480 Bunker Lake Blvd NW, Anoka, MN 55304
Phone
(763) 712-9854
(763) 506-9962 (Fax)

Professional information

Jeffrey Williams Photo 1

Jeffrey Williams

Work:
CATALYST MIDWEST, LLC
President / CEO
VITALMEDIX, INC - Hudson, WI
President / CEO and Director
UNIVERSITY OF MINNESOTA VENTURE CENTER - Minneapolis, MN
CEO in Residence
CYSTOMEDIX, INC - Andover, MN
President / CEO and Director
BRENNEN MEDICAL - White Bear Lake, MN
Vice President of Operations / Director of Operations
NOVARTIS - Saint Louis Park, MN
Director of New Ventures, Clinical Products
MEDTRONIC - Fridley, MN
Manager, Drug Administration Devices and Systems Group
ABBOTT LABORATORIES - North Chicago, IL
Clinical Program Manager, Pharmaceutical Products Division
Education:
Purdue University - West Lafayette, IN
Master of Science in Pharmacology
Northland College - Ashland, WI
Bachelor of Science in Biology and Chemistry


Jeffrey W Williams Photo 2

Jeffrey W Williams, Andover MN - OD (Doctor of Optometry)

Specialties:
Optometry
Address:
3480 Bunker Lake Blvd NW, Andover 55304
(763) 712-9854 (Phone), (763) 506-9962 (Fax)
Languages:
English


Jeffrey Williams Photo 3

Electro-Nerve Stimulator System And Methods

US Patent:
7536226, May 19, 2009
Filed:
Oct 18, 2002
Appl. No.:
10/492578
Inventors:
Jeffrey M. Williams - Andover MN, US
Fred Van Aart - Lage Zwaluwe, NL
Hans Van Den Biggelaar - Haaren, NL
Petronella Maria Coleta van Laanen, legal representative - Boekel, NL
Assignee:
Uroplasty, Inc. - Minnetonka MN
International Classification:
A61N 1/00
US Classification:
607115
Abstract:
An electro-nerve stimulation apparatus includes a pulse generator, a first electrically conductive, insulated lead wire, a second electrically conductive, insulated lead wire, an electrically conductive transcutaneous electrode and an electrically conductive percutaneous needle electrode. Connected to one end of the first and second lead wires is a connector for electrically coupling with the pulse generator. The transcutaneous electrode is operably connected to the other end of the first lead wire. An electrically conductive adaptor is secured to the other end of the second lead wire for electrically coupling to the terminal end of the percutaneous needle electrode. The lead wire set includes a single-use mechanism adapted to effectively discourage reuse of the electrodes. In use, the transcutaneous electrode is adhered to the patient's skin distal from the desired internal stimulation site. The percutaneous needle electrode is inserted through the skin in proximity to the desired internal stimulation site.


Jeffrey Williams Photo 4

Lead Set For Nerve Stimulator And Method Of Operation Thereof

US Patent:
2008003, Feb 14, 2008
Filed:
May 17, 2007
Appl. No.:
11/804200
Inventors:
Johannes Van Den Biggelaar - Haaren, NL
Jeffrey Williams - Andover MN, US
Marc Herregraven - Falcon Heights MN, US
Paul Sandstrom - Andover MN, US
Anthony Schauer - Hudson WI, US
International Classification:
A61N 1/02
US Classification:
607116000
Abstract:
Single-use electrical leads for a nerve stimulator are disclosed. The leads include a status flag element such as a fuse, which is deliberately blown after use of the leads has begun to indicate that the leads are not to be reused. The nerve stimulator has a “test mode” that determines a current value for treatment, and a “therapy mode” that administers treatment with the chosen current value. If the fuse in the electrical leads is blown (not conducting), then the stimulator assumes that the leads have already been used and does not enter therapy mode, and optionally may not enter test mode. If the fuse in the electrical leads is intact (conducting), or not blown, then the stimulator assumes that the leads are as yet unused, and allows the user to enter either test mode or therapy mode. The fuse is deliberately blown after a particular amount of time spent in therapy mode. After the fuse is blown, the user may still complete the therapy mode, even though the fuse is non-conducting, although the user may not initiate another therapy mode (and optionally may not initiate another test mode) using the blown leads. Preferably the fuse is electrically isolated from the leads that contact the patient.


Jeffrey Williams Photo 5

Implantable Neuromodulation System And Method

US Patent:
7729772, Jun 1, 2010
Filed:
Jan 7, 2005
Appl. No.:
10/905501
Inventors:
Jeffrey M. Williams - Andover MN, US
Hans van den Biggelaar - Haaren, NL
Assignee:
Uroplasty, Inc. - Minnetonka MN
International Classification:
A61N 1/36
US Classification:
607 41
Abstract:
An implantable neuromodulation system and method of treating a patient through neuromodulation of a patient's body tissue. The neuromodulation system includes a portable transmitter and an implantable receiver. The implantable receiver includes one or more electrodes disposed on the distal end of one or more elongated, flexible insulated leads. The transmitter is programmable with a treatment protocol to cause the transmitter to generate a pulsed, alternating magnetic field in accordance with the treatment protocol. When the transmitter is placed in close proximity to the receiver, the alternating magnetic field pulses generated by the transmitter cause the receiver to operably generate stimulating pulses delivered via the electrode(s) to the targeted tissue of the patient.